A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

NCT06807268 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer